Neoadjuvant Anti-PD1 in HCC
Clinical trial NCT05471674 · COMPLETED
Trial details
- NCT number
- NCT05471674
- Sponsor
- Dr Tan-to CHEUNG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2022-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.